Ownership history in Opaleye Management Inc. · 8 quarters on record
This page tracks every 13F SEC filing in which Opaleye Management Inc. reported a position in PROTALIX BIOTHERAPEUTICS INC (PLX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 2,478,176 | -102,380 | -4.0% | 0.59% | $4.5M | $1.80 |
| 2025 Q3 | ADDED | 2,580,556 | +1,580,556 | +158.1% | 0.81% | $5.7M | $2.22 |
| 2019 Q2 | REDUCED | 1,000,000 | -1,500,000 | -60.0% | 0.14% | $469K | $4.70 |
| 2018 Q4 | UNCHANGED | 2,500,000 | — | 0% | 0.29% | $777K | $3.10 |
| 2018 Q3 | REDUCED | 2,500,000 | -600,000 | -19.4% | 0.46% | $1.8M | $7.30 |
| 2018 Q2 | REDUCED | 3,100,000 | -160,000 | -4.9% | 0.35% | $1.3M | $4.30 |
| 2018 Q1 | ADDED | 3,260,000 | +1,435,000 | +78.6% | 0.50% | $1.8M | $5.40 |
| 2017 Q4 | INITIATED | 1,825,000 | — | — | 0.39% | $1.2M | — |
As of 2025 Q4 — sorted by position size